Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers.
Racine É, Boivin G, Longtin Y, McCormack D, Decaluwe H, Savard P, Cheng MP, Hamelin MÈ, Carbonneau J, Tadount F, Adams K, Bourdin B, Nantel S, Gilca V, Corbeil J, De Serres G, Quach-Thanh C. Racine É, et al. Among authors: nantel s. Influenza Other Respir Viruses. 2022 Sep;16(5):916-925. doi: 10.1111/irv.12997. Epub 2022 May 5. Influenza Other Respir Viruses. 2022. PMID: 35510653 Free PMC article.
Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine.
Nantel S, Bourdin B, Adams K, Carbonneau J, Rabezanahary H, Hamelin MÈ, McCormack D, Savard P, Longtin Y, Cheng MP, De Serres G, Corbeil J, Gilca V, Baz M, Boivin G, Quach C, Decaluwe H. Nantel S, et al. Front Immunol. 2022 Oct 14;13:930252. doi: 10.3389/fimmu.2022.930252. eCollection 2022. Front Immunol. 2022. PMID: 36311736 Free PMC article.
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity.
Nantel S, Sheikh-Mohamed S, Chao GYC, Kurtesi A, Hu Q, Wood H, Colwill K, Li Z, Liu Y, Seifried L, Bourdin B, McGeer A, Hardy WR, Rojas OL, Al-Aubodah TA, Liu Z, Ostrowski MA, Brockman MA, Piccirillo CA, Quach C, Rini JM, Gingras AC, Decaluwe H, Gommerman JL. Nantel S, et al. Mucosal Immunol. 2024 Apr;17(2):201-210. doi: 10.1016/j.mucimm.2024.01.004. Epub 2024 Jan 24. Mucosal Immunol. 2024. PMID: 38278415 Free article.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Stubbins RJ, Stamenkovic M, Roy C, Rodrigo J, Chung S, Kuchenbauer FC, Hay KA, White J, Abou Mourad Y, Power MM, Narayanan S, Forrest DL, Toze CL, Sutherland HJ, Nantel SH, Nevill TJ, Karsan A, Song KW, Sanford DS. Stubbins RJ, et al. Among authors: nantel sh. Eur J Haematol. 2022 May;108(5):437-445. doi: 10.1111/ejh.13752. Epub 2022 Feb 14. Eur J Haematol. 2022. PMID: 35122325
Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population.
Cherniawsky HM, AlAhwal H, Mourad YA, Forrest D, Gerrie A, Kuchenbauer F, Nantel SH, Narayanan S, Nevill T, Power M, Sanford D, Toze C, White J, Escano L, Sutherland H, Song K. Cherniawsky HM, et al. Among authors: nantel sh. Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):476-482. doi: 10.1016/j.clml.2021.02.012. Epub 2021 Mar 4. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33814336
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center.
Kodad SG, Sutherland H, Limvorapitak W, Abou Mourad Y, Barnett MJ, Forrest D, Gerrie A, Hogge DE, Nantel SH, Narayanan S, Nevill T, Power M, Sanford D, Toze C, White J, Broady R, Song K. Kodad SG, et al. Among authors: nantel sh. Clin Lymphoma Myeloma Leuk. 2019 Dec;19(12):784-790. doi: 10.1016/j.clml.2019.09.619. Epub 2019 Oct 9. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31678079
High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
Tsang ES, Villa D, Loscocco F, Visani G, Power M, Guiducci B, Clissa C, Song K, Toze C, Abou Mourad Y, Sutherland H, Sanford D, Nantel SH, Sehn LH, Scott DW, Savage KJ, Connors JM, Gerrie AS, Isidori A. Tsang ES, et al. Among authors: nantel sh. Bone Marrow Transplant. 2019 Mar;54(3):481-484. doi: 10.1038/s41409-018-0328-9. Epub 2018 Aug 31. Bone Marrow Transplant. 2019. PMID: 30171222 No abstract available.
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Limvorapitak W, Barnett MJ, Hogge DE, Forrest DL, Nevill TJ, Narayanan S, Power MM, Nantel SH, Broady R, Song KW, Toze CL, Mourad YA, Sutherland HJ, Gerrie AS, White J, Sanford DS. Limvorapitak W, et al. Among authors: nantel sh. Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):e481-e491. doi: 10.1016/j.clml.2018.07.290. Epub 2018 Jul 17. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30100330 Clinical Trial.
99 results